** Shares in Oriola OKDBV.HE fall 8.5% as the Finnish drug
distributor reports first quarter results falling year on year
urn:newsml:reuters.com:*:nFWN2MJ1EW
** Oriola reports sales, operating profit falling due to low
pharmaceutical volumes amid the COVID-19 pandemic, says
situation remains unclear
** We expected it would be fairly easy to outdo weak
comparable numbers from 2020, Inderes analyst Petri Kajaani says
** Q1 adjusted operating profit fell to 300,000 euros
($362,000), while Inderes expected Q1 number unchanged from 6.9
million euros reported in Q1 2020
** Following the weak Q1 report the risk of a delay in
turnaround in results seems to have increased, Kajaani adds
** Oriola stock top faller on OMX Helsinki All-Share Index
.OMXHPI
($1 = 0.8285 euros)
((boleslaw.lasocki@tr.com))